Bevacizumab vs Insulin Glargine

## Bevacizumab vs Insulin Glargine: Overview

This comparison examines the pharmacological differences between **Bevacizumab** and **Insulin Glargine**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

## Pharmacokinetics

**Half-life**: Bevacizumab — N/A; Insulin Glargine — 12-24 hours.

## Chemical Properties

**Type**: Bevacizumab — Antibody; Insulin Glargine — Protein.